Bright Minds Biosciences

Is Psilocybin Depression Therapy Future Of Mental Health Care?

Today, depression is undeniably one of the major public health concerns. This particular mental disorder is accompanied by worthlessness, exhaustion& sadness. It has already impacted around 320 million of individuals worldwide.The conventional therapies that are available today are not as effective as they should be. The rate of suicide is increasing at an alarming pace. Due to this, there is a requirement of developing novel, transformative interventions for curing depression. Some of psychedelics have shown their potential as interventions for depression. Although, it might be difficult to imagine that the elicit psilocybin, called as magic mushrooms can be utilized in clinical settings. However, it is exactly where the future of the mental health care industry life.

The New Wave Of Research Is Paving Its Way Towards Integrated Psilocybin Depression

The recent developments in this particular field provide a completely new understanding and potential of curing otherwise intractable mental health conditions. However, one of the biggest challenges that lie ahead of the patients as well as physicians is to overcome the negative stigma associated with its utilization.

Psilocybin has huge potential and recent evidence suggested that the psychoactive action is based upon the capability of the compound to stimulate one of the specific serotonin receptors by the name of 5HT2A.

Psilocybin Depression Therapy Is More Effective Than Conventional Antidepressants

Till date, some of research has found psilocybin depression effective due to its promising results. This particular psychedelic drug encompasses most clinical evidence for being effective in curing severe depression. One of the studies conducted at John Hopkins University found that psilocybin depression therapy is four times more effective in comparison to conventional antidepressants. 2/3rd of the participants have witnessed a greater than 50% reduction in depressive signs in the duration of just a week. This particular novel transformative therapy may provide hope to psychiatrists in hopeless cases. Quite a large number of clinical trials of psilocybin depression that are underway in the USA and some European countries aim to win the approval of the regulatory authorities. Two of the clinical trials have already enrolled 300+ patients in 10 nations of the world granted the status of breakthrough therapy in the years 2018 & 2019 by the FDA.

The Rehabilitation Of Psilocybin Depression Treatment Raises Few Concerns As Well

If such trials become successful, then a new protocol for psilocybin depression therapy in clinical settings could actually be established in a fast manner. However, the rehabilitation of psilocybin depression treatment raises a few concerns as well. Some of the researchers are worried about the utilization of psychedelic drugs as it may induce psychosis. But still, many scientists worldwide believe that the risk of the psychedelic pale against the potential advantages it provides. This is including not only the effective psilocybin depression therapy but also a completely new understanding about several of mental health illnesses. The scientists stated that they are fully convinced about the positive impact of psychedelic drugs that are quite profound. This has also been found to be relevant about the understanding and development of innovative approaches toward brain disorders.